面对入世后世界医药经济、科技格局的明显变化 ,以及我国《药品注册管理办法》的全面推行 ,国际、国内医药经济和技术市场发生了重大转变 ,同时也呈现出更大的机遇与挑战。随着我国大多数制药企业GMP建设临近尾声 ,药企对新技术新产品的需求越来越迫切 ,同时国外许多新药研发机 Faced with the marked changes in the world’s pharmaceutical economy and science and technology after China’s accession to the WTO, as well as the full implementation of the “Measures for the Administration of Drug Registration” in China, significant changes have taken place in the international and domestic pharmaceutical economy and technology markets, while presenting greater opportunities and challenges. With the majority of pharmaceutical companies in China near the end of GMP building, pharmaceutical companies demand for new technology and new products more and more urgent, while many foreign drug development machine